Pharmacybrands to lift directors' fees, introduce dividend reinvestment

Pharmacybrands to lift directors' fees, introduce dividend reinvestment
By Paul McBeth July 06 (BusinessDesk) - Pharmacybrands, the retail pharmacy and medical centre company, will ask shareholders to approve a 22 percent hike in its pool for directors' fees and sign off on the implementation of a dividend reinvestment plan at next month's annual meeting. The maximum aggregate remuneration for the Auckland-based company's board will rise to $380,000 from $310,000 taking effect from April of this year if shareholders approve the resolution. Pharmacybrands' directors haven't had the pool raised since 2005, and the...